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120Femoral artery calciﬁcation as a determinant of
success for percutaneous access for endovascular
abdominal aortic aneurysm repair
Jesse M. Manunga, MD, Peter Gloviczki, MD, Gustavo S. Oderich, MD, Manju Kalra, MBBS,
Audra A. Duncan, MD, Mark D. Fleming, MD, and Thomas C. Bower, MD, Rochester, Minn
Objective: This study was conducted to determine the outcomes and predictive factors for success during percutaneous
endovascular aneurysm repair (PEVAR) using vascular closure devices (VCDs).
Methods: The clinical data of patients who underwent PEVAR between 2005 and 2012 were retrospectively reviewed.
Patient demographics, body mass index, sheath size, device types, diameter of femoral arteries, and extent and location of
femoral artery calciﬁcation were recorded. Included were all consecutive patients treated by PEVAR with sheath sizes
ranging from 12F to 24F. End points were technical success, conversion to open femoral artery repair, and complications.
Results: During this period, 752 patients were treated by EVAR. Of these, 391 femoral arteries in 222 patients (29.5%;
197 men, 25 women), with a mean age of 74.8 years (range, 51-93.7 years), underwent PEVAR (169 bilateral and 53
unilateral percutaneous access). Patients with >50% anterior femoral artery calciﬁcations or those with previous femoral
artery reconstructions were not offered PEVAR. Technical success of PEVAR was 96.4% (377 of 391), with an average of
two VCDs used per groin. Fourteen intraoperative failures were managed with open femoral conversion using primary
repair (ﬁve) or patch angioplasty (nine). In nine patients, the procedure was converted from local to general anesthesia.
Four patients required a perioperative blood transfusion. There were no signiﬁcant differences in body mass index (P [
.26), femoral artery size preprocedure (P [ .33) or postprocedure (P [ .37), sheath size ($20F vs #18F), or type of
VCD used between the success and failure groups. Pairwise comparisons revealed increased failure rate (P < .001) between
patients with <50% anterior wall calciﬁcation vs none, <50% anterior wall calciﬁcation vs <50% posterior wall calciﬁcation,
and none vs >50% posterior calciﬁcation. There was no signiﬁcant difference (P [ .53) between patients with <50%
posterior wall calciﬁcation and those with no calciﬁcation. The 30-day mortality of the entire group was 0.9% (2 of 222
patients). No deaths occurred after conversion to open femoral closure. At a mean follow-up of 30 months (range, 1-85.2
months), there were no long-term groin complications or iliac limb occlusions.
Conclusions: PEVAR using VCDs can be performed with high technical success in patients with <50% anterior wall
calciﬁcation, regardless of the size of the access sheath or the patient’s body mass index. Femoral artery calciﬁcation,
however, is a major determinant of failure. (J Vasc Surg 2013;58:1208-12.)Since their introduction in the mid-1990s, the use of
vascular closure devices (VCDs) has gained traction, and
they are now being applied to close large-bore arterial punc-
tures after percutaneous endovascular abdominal aortic
aneurysm repair (PEVAR).1 Although this use is outside of
the manufacturer instructions for use, most published series
have reported technical success rates ranging from 66% to
100% after PEVAR.2-4 The reported reduction of complica-
tions associated with groin cutdown, such as infection, lymph
leak, and the resulting decreased in hospital length stay, make
this technique appealing. Undoubtedly, the popularity ofthe Division of Vascular and Endovascular Surgery, Gonda Vascular
enter, Mayo Clinic.
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8PEVAR will continue to rise as industries develop low-
proﬁle stent grafts and newer-generation VCDs.
Although little consensus exists on factors predicting
success of PEVAR, femoral artery calciﬁcation, morbid
obesity, large sheath size, groin scar, and operator experi-
ence have been reported as predictors of technical fail-
ures.1-4 We conducted a retrospective review of all patients
treated with PEVAR at our institution from 2005 to 2012
to determine the outcomes and predictive factors for success
after this technique.
METHODS
The Institutional Review Board approved this retro-
spective study of all patients treated by PEVAR at our insti-
tution between 2005 and 2012. Included were all
consecutive patients treated electively by this technique
with sheath sizes ranging from 12F to 24F. The study
excluded patients treated emergently for ruptured or
urgently for symptomatic aneurysms.
Data collected included patient age, sex, body mass
index, and cardiovascular risk factors, and sheath size,
type of stent graft, and VSD used. For each patient, at least
one preoperative and postoperative computed tomography
(CT) scan were reviewed, with particular attention paid to
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the size of the artery before and after PEVAR.
Patients were divided into four groups according to
the extent of arterial calciﬁcation as documented on the
preoperative CT scan. Those whose anterior femoral arteries
were completely calciﬁed in the 9 o’clock to 3 o’clock posi-
tion from the inguinal ligament to the profunda bifurcation
were classiﬁed as having 50% anterior femoral artery calciﬁca-
tion. Those with scattered calciﬁcation in the anterior aspect
were classiﬁed as having <50% femoral artery calciﬁcation.
Patients with posterior femoral artery calciﬁcation were clas-
siﬁed in similarmanner (>50% vs<50%).Thedegree of calci-
ﬁcation was assigned retrospectively. Patients with >50%
anterior femoral wall calciﬁcation and those with previous
femoral artery reconstruction were not offered PEVAR.
A single senior vascular surgery fellow reviewed all CT
scans and assigned the degree of femoral artery calciﬁcation.
Since 2006, all percutaneous vascular accesses for
EVAR have been performed under ultrasound guidance
in our division. This allows puncture of the common
femoral artery (CFA) above the bifurcation while avoiding
area of heavy calciﬁcation. We use a stiff micropuncture kit
to gain access. Once vascular access is achieved, the micro-
puncture system is exchanged for a 0.035-inch system,
usually a Bentson wire (Cook Medical Inc, Bloomington,
Ind), and a 6F sheath is put in place. We use two different
vascular closure devicesdPerclose ProGlide and Prostar XL
(Abbott Vascular, Redwood City, Calif). The “perclose”
technique is accomplished by placing two VCDs on each
side before upsizing to a large-bore sheath and completing
the procedure in the usual fashion.
At the completion of the case, we preferentially replace
the superstiff wire with the previously used Bentson wire or
a soft or stiff angled glidewire before securing the VCDs in
place. The wire is not taken out until we are certain appro-
priate hemostasis has been achieved. If there is no hemo-
stasis, a third VCD is placed, and if still unsuccessful, the
sheath is reintroduced and proximal control is obtained
using a balloon before exposing the artery for repair. This
helps reduce the amount of blood loss experienced in
case of VCD failure.
Descriptive statistics are reported as number (percentage)
or as median (range), as appropriate. Estimates of failure
rates are reported along with a 95% exact binomial conﬁ-
dence interval (CI). Associations of variables with failure
or success are assessed using a c2 test (or Fisher exact test)
or Wilcoxon rank sum test, as appropriate. These assess-
ments with failure have assumed independence for the 391
femoral arteries in the 222 patients. Because the overall asso-
ciation of CFA calciﬁcation with failure rate was signiﬁcant,
we have reported the unadjusted P values for the six pairwise
comparisons among the four calciﬁcation groups.
Bonferroni-adjusted P values required a P < .008 for signif-
icance. The a level was set at .05 for statistical signiﬁcance.
RESULTS
During the study period, 725 patients underwent elec-
tive EVAR at our institution. Of these, 222 patients(197 men, 25 women) had percutaneous closure of 391
large-bore ($12F) femoral access sites after EVAR using
VCDs. Both femoral arteries were accessed percutaneously
in 169 patients, and 52 patients underwent a groin cut-
down on one side and percutaneous access on the contra-
lateral side. The PEVAR patients were a mean age of
74.8 years (range, 51-93.7 years) and had a mean body
mass index of 28.5 kg/m2. Table I summarizes the demo-
graphic and cardiovascular risk factors of the patients
included in the study.
Technical success was 96.4% (377 of 391 arteries), with
an average of two VCDs used per groin and a maximum of
three VCDs. However, the per patient technical success
was 93.7% (14 of 222 patients). There were no statistically
signiﬁcant differences in the success and failure rates
between the two types of closure devices that were used
(Perclose ProGlide and Prostar XL). There were 14 intra-
operative access failures after PEVAR, which were managed
with groin cutdown and repair of the artery. The repair in
ﬁve patients was performed with primary closure, with or
without pledgets. In nine patients, however, the femoral
artery was reconstructed with a bovine pericardial patch
(Table II). All failures were noticed at the completion
of the procedure while trying to secure the VCDs to the
arterial wall.
The procedure in nine of 14 patients had to be con-
verted from local to general anesthesia. In addition, four
of the 14 patients who required conversion to standard
EVAR received a blood transfusion perioperatively. Three
of these patients were extubated the following day in the
intensive care unit (ICU). The fourth patient was extu-
bated the same evening in the ICU. On average, conver-
sion to standard EVAR after failed PEVAR resulted in an
overnight ICU admission in four patients and increased
by 2 days the overall hospital length of stay in this group.
In most patients, the cause of failure after conversion to
standard EVAR was the inability of the VCD needle to
engage the heavily calciﬁed wall of the femoral artery. In
one patient, however, the cause of failure was attributed
to the suture being tangled up with the superstiff wire
used to deliver the stent graft.
Univariate analysis revealed no statistically signiﬁcant
association of access failure with sex (P ¼ .17), BMI
(P ¼ .26), preprocedure or postprocedure femoral artery
size (P ¼ .33), sheath size categorized as <20F vs >20F
(P ¼ .47), type of stent graft used (P > .99), or type of
VCD used (P ¼ .70; Tables III and IV). Overall, there
was a signiﬁcant association for CFA calciﬁcation with
failure (P < .001), with rates of failure of 83.3% (95%
CI, 51.6%-97.9%) for <50% anterior calciﬁcation, 15.4%
(95% CI, 1.9%-45.4%) for >50% posterior calciﬁcation,
0.9% (95% CI, 0.02%-4.8%) for <50% posterior calciﬁca-
tion, and 0.4% (95% CI, 0.01%-2.2%) for no femoral calci-
ﬁcation. Pairwise comparisons identiﬁed femoral arteries
with <50% anterior wall calciﬁcation had a signiﬁcantly
higher failure rate than each of the other three groups, vs
no femoral artery calciﬁcation (P < .001), vs <50%
posterior wall calciﬁcation (P < .001), and vs >50%
Table II. Technical success and complications after
percutaneous access for endovascular abdominal aortic
aneurysm repair
Variable
Sheath diameter
Total
(n ¼ 391) P
$20F
(n ¼ 62)
<20F
(n ¼ 329)
Conversion, No. (%) 3 (4.8) 11 (3.3) 14 (3.6)
Type of repair, No. .16
Primary repair 1 4 5
Patch angioplasty 2 7 9
Post-op complications 1a 0 1
aThrombosed right iliac limb at day 9 treated successfully with open surgical
thrombectomy and stenting of the limb.
Table I. Demographic and cardiovascular risk factors
of 222 patients undergoing percutaneous access for
endovascular abdominal aortic aneurysm repair
Variable Outcome (n ¼ 222)
Type of access, No. (%)
Bilateral percutaneous 169 (76)
Unilateral percutaneous 53 (24)
Percutaneous vessels 391 (100)
Age, mean (SD) years 74.8 (8.8)
Gender, No. (%)
Male 197 (89)
Female 25 (11)
BMI, mean (SD) kg/m2 28.5 (4.8)
Cardiovascular risk factors, No. (%)
Diabetes 51 (23)
Hypertension 198 (89)
Coronary artery disease 113 (51)
Cerebrovascular disease 62 (28)
Chronic kidney disease 66 (30)
Hyperlipidemia 147 (66)
Smoking 169 (76)
Peripheral arterial disease 21 (10)
BMI, Body mass index; SD, standard deviation.
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differences also existed for >50% posterior wall calciﬁcation
vs no femoral artery calciﬁcation (P ¼ .01) and for >50%
posterior wall calciﬁcation vs <50% posterior wall calciﬁca-
tion vs 50% posterior wall calciﬁcation (P ¼ .03). The
failure rate of <50% posterior wall calciﬁcation was not
signiﬁcantly higher than for arteries with no femoral artery
calciﬁcation (P ¼ .53).
The 30-day mortality rate was 0.9% (two of 222
patients; 95% CI, 0.1%-3.2%). The cause of death was heart
failure after failed cardiac catheterization in one patient and
myocardial infarction in the other. No deaths occurred
after conversion to open femoral artery closure or repair.
One iliac limb occlusion occurred #30 days in a patient
who presented with short-distance claudication 9 days after
being discharged from the hospital. The thrombosed iliac
limb was successfully treated with open thrombectomy
and stenting of a kinked iliac limb. At a mean follow-up
of up to 30 months (range, 1-82.2) no long-term groin
complications and no limb occlusion had occurred.
DISCUSSION
Total PEVAR has grown to become an attractive
alternative to EVAR performed with traditional groin cut-
downs. Case series have suggested the technique decreases
the rate of wound infection, lymph leak, estimated blood
loss, and even hospital length of stay.5,6 As with any new
technology, there is a learning curve associated with
mastering the “perclose” technique.7 The technical success
rate of PEVAR as currently reported ranges from 62% to
100%.8 We report an overall success rate of 96.4% in 391
vessels accessed percutaneously for EVAR during a 7-year
interval (Table II).
According to published reports; factors negatively
affecting success of PEVAR include obesity, scarred groinsfrom previous interventions, size of the femoral artery, high
femoral bifurcation, and vessel tortuosity.8-10 Our study
failed to conﬁrm that obesity, type of the two closure
devices used, or size of the femoral artery or sheath size
negatively affected the success of PEVAR (Tables III
and IV). Women were twice more likely than men (7.3%
vs 3.1%) to experience failure of PEVAR (Table IV).
This difference did not reach statistical signiﬁcance, but
likely would with a larger sample size. In fact, some have
reported small vessel size as a predictor of failure of
PEVAR.5 The reason for this failure likely is because
women tend to have smaller vessels than men.
We cannot rule out scarred groins as predictors of
VCDs failure during PEVAR, because in our experience,
patients with previous femoral artery reconstruction were
not offered elective PEVAR. High bifurcation or vessel
tortuosity did not affect outcome of PEVAR. The reason
for this discrepancy might be because we routinely access
the femoral artery under ultrasound guidance to minimize
injury or a puncture of the profunda femoris artery.
We agree with Eisenack et al11 and others8,10 that
femoral artery calciﬁcation negatively affects success rate
of PEVAR (Table IV). A review of the location and extent
of femoral artery calciﬁcation on preoperative CT scans was
equally important in predicting the outcome of PEVAR.
Pairwise comparison revealed that patients with <50%
anterior femoral artery calciﬁcation had the highest likeli-
hood of failure (P < .001), followed by those with <50%
calciﬁcations. There was no statistically signiﬁcant differ-
ence in failure rate between patients with <50% posterior
femoral artery calciﬁcation and those with >50% posterior
femoral calciﬁcation. This ﬁnding makes sense, because the
Perclose device works by placing 3-0 polyester sutures with
a preformed slipknot that is subsequently used to close the
arteriotomy with the help of a dedicated knot pusher.
Failure in calciﬁed vessels occurs due to the inability of
this suture to be secured in the femoral artery.
All patients included in the study had at least one CT
scan before and after EVAR. Review of these scans showed
no signiﬁcant narrowing in the size of the femoral artery
after PEVAR (Table III). Although not every patient in
our cohort had noninvasive vascular laboratory assessments
Table III. The effect of body mass index (BMI) and common femoral artery (CFA) size on failure of percutaneous access
for endovascular abdominal aortic aneurysm repair (PEVAR)
Variable Failure median (range) Success median (range) P
BMI, kg/m2 29.6 (20.9-40.6) 28.0 (17.0-48.2) .26
CFA size
Pre-PEVAR, mm 7.9 (7.0-9.0) 8.0 (6.7-11.0) .27
Post-PEVAR, mm 7.6 (7.0-8.8) 7.8 (6.5-10.8) .33
Change post-pre, mm 0.1 (0.4 to 0.0) 0.1 (0.8 to 1.6) .37
Change post-pre, % 1 (5 to 0) 1 (10 to 23) .67
Table IV. The effect of femoral artery calciﬁcation, sex,
stent graft, and femoral artery closure device on failure of
percutaneous access for endovascular abdominal aortic
aneurysm repair
Variable No.
Failure
No. (%) 95% CI (%) Pa
Overall 391 14 (3.6) (2.0-5.9)
CFA calciﬁcation <.001
None 251 1 (0.4) (0.01-2.2)
<50% posterior 115 1 (0.9) (0.02-4.8)
>50% posterior 13 2 (15.4) (1.9-45.4)
<50% anterior 12 10 (83.3) (51.6-97.9)
>50% anterior 0
Device used >.99
Cookb 130 5 (3.8) (1.3-8.8)
Gorec 201 8 (4.0) (1.7-7.7)
Endurantd 40 1 (2.5) (0.1-13.2)
AneuRx/Endologixd 20 0 (0.0) (0.0-16.8)
Sex .17
Male 350 11 (3.1) (1.6-5.6)
Female 41 3 (7.3) (1.5-19.9)
Closure device .70
Perclosee 357 14 (4.0) (2.2-6.6)
Prostare 34 0 (0.0) (0.0-10.3)
Sheath size
<20F 329 11 (3.3) (1.7-5.9)
$20F 62 3 (4.8) (1.0-13.5) .47
CFA, Common femoral artery; CI, conﬁdence interval.
aPairwise comparisons with signiﬁcant differences in rates of failure: <50%
anterior vs none, P < .001; <50% anterior vs <50% posterior, P <
.001; <50% anterior vs >50% posterior, P ¼ .001; none vs >50% posterior,
P¼ .01;<50% posterior vs>50% posterior, P¼ .03; none vs<50% posterior
was not signiﬁcant (P ¼ .5).
bCook Medical, Indianapolis, Ind.
cW. L. Gore & Associates, Flagstaff, Ariz.
dMedtronic, Minneapolis, Minn.
eAbbott Vascular, Redwood City, Calif.
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and only one required femoral artery endarterectomy at 32
months after EVAR.
There were 14 failures (3.6%) in our entire cohort. In
every case, failure required conversion to femoral artery
cutdown and repair of the artery. Because the Bentson
wire is not removed until satisfactory hemostasis is ob-
tained, we were able to replace the large-bore sheath
and, at times, use a balloon to obtain proximal control in
case of Perclose failure, thus limiting the amount of blood
loss. Five arteries were repaired primarily with interrupted,at times pledgeted, Prolene (Ethicon, Somerville, NJ)
sutures after groin cutdown. The arteries in the other
nine patients were reconstructed after endarterectomy
with or without patch angioplasty. The procedure in these
nine patients was converted from a local anesthetic with
monitor care to an endotracheal intubation to allow for
the repair of artery and hemodynamic stabilization.
With the exception of one, all failures were noticed
immediately in the operating room as pulsatile bleeding
and inability to achieve hemostasis in the groin. Four of
these 14 patients required blood transfusion, and all stayed
overnight in the ICU for close observation but were down-
graded to ﬂoor status the next day, delaying their hospital
discharge by an average of only 2 days.
The patient presenting with claudication and limb
thrombosis on postoperative day 9 was relatively young
and had soft, noncalciﬁed vessels. The cause of failure
was believed to be a kink in the iliac limb detected during
the second procedure. His claudication completely
resolved after a groin cutdown, thrombectomy, and stent-
ing of the limb.
There were no deaths after conversion to open repair of
the femoral artery. A 30-day mortality of 0.9% compares
favorably with other published reports. At a mean follow-
up of 30 months, there were no long-term groin complica-
tions or iliac limb occlusions, with the one exception stated
above.
Since 2006, it is customary in our department to percu-
taneously access vessels using a micropuncture needle
under ultrasound guidance. We believe this helps decrease
failure rate of PEVAR because areas of heavy calciﬁcations
are detected by ultrasound imaging, and access in these
areas can be avoided (Fig). Not all failures were due to
calciﬁcations. Failure in one patient was due to the suture
being caught on the Lunderquist wire (Cook Medical
Inc), leading to the inability of the suture to engage the
femoral artery.
Our study has several limitations. The ﬁrst stems from
its retrospective nature and the inability to determine the
surgeon’s preoperative intention to treat.
Second, the study has a built-in selection bias because
all patients had a preoperative CT scan that allowed
surgeons to select for PEVAR only patients without heavily
calciﬁed femoral arteries.
Third, our division did not have an established protocol
on when to offer a patient PEVAR. Indications for this
Fig. A, A computed tomography angiogram shows a patient with heavily calciﬁed anterior femoral artery wall. Percu-
taneous access for endovascular abdominal aortic aneurysm repair failed in this patient because the Perclose needle was not
able to engage the heavily calciﬁed femoral arterial wall. B, Left common femoral artery of a patient with<50% posterior
wall calciﬁcation. This artery was successfully closed with two Perclose devices.C, Patient with scattered bilateral femoral
artery calciﬁcations. In this case, noncalciﬁed portions of both femoral arteries were accessed percutaneously using
ultrasound guidance and successfully closed with the vascular closure device.
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patients with suitable femoral and iliac artery anatomy are
offered the procedure. However, this was not the case
before 2008, when only a handful of patients were treated
in this manner regardless of their anatomic suitability.
Fourth, CT scan reviews and degree of femoral artery
calciﬁcations were assigned by a single individual with
knowledge of patients’ clinical outcome, thus creating
a potential for reader bias.
Lastly, PEVAR was not offered to patients who had
undergone previous femoral artery reconstructions, and
thus, the ﬁndings of the current study do not apply to patients
who have had previous femoral artery reconstructions.
CONCLUSIONS
Our study shows that PEVARwith a Perclose technique
using VCDs is safe and has a high success rate, regardless of
the sheath size and femoral artery size. Calciﬁcation, espe-
cially the presence of anterior femoral artery calciﬁcation,
is the major determinant of failure of PEVAR. With experi-
ence, a success rate of >96% can be expected in carefully
selected patients. Groin cutdown after failed PEVAR may
require conversion to general anesthesia, ICU stay, and
need for blood transfusion but did not increase limb
ischemia, wound complications, or early death in this study.
We thank Scott (William) Harmsen for statistical
support.
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